Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Promethera Biosciences
227
Promethera Biosciences
Technology
Biotechnology
Health Care
Medical
Therapeutics
Promethera Biosciences is a biopharmaceutical company focused on cell therapyproducts to treat liver diseases.
Suggest edits
Founded
2009
Raised
$92.9M
Follow us
Companies in the same industry
Tioma Therapeutics
Proclara Biosciences
Oncorus
ELSALYS BIOTECH
Kyn Therapeutics
Edgewise Therapeutics
Fountain Therapeutics
TARA Biosystems
Centauri Therapeutics Limited
TapImmune
Alexa global traffic share
Overview
Funding
5
Add info
Add round
10 Apr
2018
€9,300,000
Debt financing
Shinsei Corporate Investment Limited
,
Shibuya Corporation
Promethera Biosciences Raises Additional €9.3M in Funding
FinSMEs
27 Oct
2016
€10,000,000
Venture capital (Series C)
Mitsui & Co. Global Investment
,
Mitsubishi UFJ Capital
,
Boehringer Ingelheim Venture Fund
,
+4
Promethera Biosciences Raises EUR 10 Million in a Series C-extension Financing to Advance its Broad Product Pipeline in Liver Diseases | Business Wire
businesswire
25 Nov
2014
$31,444,456
Venture capital (Series C)
28 Mar
2012
$31,475,320
Venture capital (Series B)
Mitsui & Co. Global Investment
,
Boehringer Ingelheim Venture Fund
,
Shire
02 Feb
2010
$7,300,000
Venture capital (Series A)
Life Sciences Partners
,
Société Régionale d'Investissement de Wallonie
,
Vesalius Biocapital